Catalogo dei prodotti della ricerca

CIMINO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.376
EU - Europa 2.335
AS - Asia 1.337
SA - Sud America 44
AF - Africa 34
OC - Oceania 3
Totale 11.129
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.279
IT - Italia 774
SG - Singapore 514
SE - Svezia 456
IN - India 441
CN - Cina 316
UA - Ucraina 245
FI - Finlandia 234
DE - Germania 167
CA - Canada 89
GB - Regno Unito 84
RO - Romania 74
BG - Bulgaria 61
RU - Federazione Russa 59
BE - Belgio 52
AR - Argentina 37
IE - Irlanda 36
TG - Togo 24
FR - Francia 23
NL - Olanda 19
GR - Grecia 18
IR - Iran 15
ID - Indonesia 13
CH - Svizzera 11
HK - Hong Kong 10
JP - Giappone 9
MX - Messico 6
PL - Polonia 5
TR - Turchia 5
ZA - Sudafrica 5
PT - Portogallo 4
BR - Brasile 3
CL - Cile 3
AL - Albania 2
AU - Australia 2
DK - Danimarca 2
ES - Italia 2
LT - Lituania 2
MY - Malesia 2
PK - Pakistan 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KR - Corea 1
LV - Lettonia 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
TW - Taiwan 1
VN - Vietnam 1
Totale 11.129
Salva come PNG Salva come JPEG
Città #
Fairfield 1.201
Woodbridge 568
Chandler 557
Ashburn 513
Houston 435
Seattle 424
Wilmington 389
Cambridge 381
Singapore 350
Ann Arbor 290
Princeton 272
Rome 248
Plano 216
San Paolo di Civitate 216
Beijing 201
Santa Clara 138
Lawrence 137
Boston 133
San Diego 93
Millbury 92
Jacksonville 87
Des Moines 83
Dearborn 72
Sofia 61
Andover 59
Brussels 52
Norwalk 50
Ottawa 42
Toronto 41
Boardman 38
Helsinki 37
Dublin 36
Federal 36
Southend 34
Bremen 33
Moscow 33
New York 26
Lomé 24
Falls Church 23
San Mateo 22
Falkenstein 21
Milan 19
Mannheim 17
Trento 17
Hefei 16
Bühl 14
Nanjing 14
Jakarta 13
Kunming 12
Bologna 10
Hong Kong 10
London 10
Los Angeles 10
Redmond 10
Buffalo 9
Paris 9
Pune 9
Fremont 8
Indiana 8
Simi Valley 8
Munich 7
Phoenix 6
Provo 6
Zurich 6
Bern 5
Catania 5
Dallas 5
Guangzhou 5
Nanchang 5
Tehran 5
Amsterdam 4
Cosenza 4
Genoa 4
Izmir 4
Jinan 4
Laurel 4
Leawood 4
Muizenberg 4
Tappahannock 4
Tokyo 4
Wuhan 4
Auburn Hills 3
Capoterra 3
Casoria 3
Fasano 3
Fiano Romano 3
Frankfurt am Main 3
Frosinone 3
Greifswald 3
Hyderabad 3
Mexico City 3
Montréal 3
Naples 3
Pavia 3
San Jose 3
San Remo 3
Shanghai 3
Zanjan 3
Zhengzhou 3
Alcamo 2
Totale 8.142
Salva come PNG Salva come JPEG
Nome #
EuPRAXIA@SPARC_LAB Design study towards a compact FEL facility at LNF 136
SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients 121
Assembly and functional analysis of an S/MAR based episome with the cystic fibrosis transmembrane conductance regulator gene 103
The therapeutic response and clinical outcome of adults with ALL1(MLL)/AF4 fusion positive acute lymphoblastic leukemia according to the GIMEMA experience. 98
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 95
Genetic lesions disrupting calreticulin 3′-untranslated region in JAK2 mutation-negative polycythemia vera 92
SUSTAINED MOLECULAR REMISSION AFTER LOW DOSE GEMTUZUMAB-OZOGAMICIN IN ELDERLY PATIENTS WITH ADVANCED ACUTE PROMYELOCYTIC LEUKEMIA 90
Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: Results of a crossover, randomized clinical trial 90
No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy 88
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: Results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol 88
Hepatitis B reactivation despite entecavir prophylaxis in a patient with chronic lymphocytic leukaemia receiving bendamustine 87
Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells 87
Reactive-Oxygen-Species-Mediated P. aeruginosa Killing Is Functional in Human Cystic Fibrosis Macrophages 86
A case of Burkitt lymphoma-L3 ALL with t(8;14)translocation, developed 10 years after Hodgkin's disease. 86
Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease 84
Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study. 84
Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen 84
Detection of BCR/ABL rearrangements in adult acute lymphoblastic leukemia using a highly sensitive interphase fluorescence in situ hybridization method (D-FISH). 82
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease 82
Evaluation of therapeutic modalities in the control of Hodgkin's disease. 80
Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression 78
HDAC inhibition by valproic acid decreases JAK2V617F levels in myeloproliferative neoplasms via up-regulation of miR-101, in vivo and in vitro 78
Adult patients affected by cystic fibrosis in therapy with cystic fibrosis transmembrane regulator modulators and lung transplant: renal function, metabolic and nutritional status 78
Haemolytic uremic syndrome during induction therapy in an acute promyelocytic leukemia patient with aberrant phenotype: a possible manifestation of retinoic acid syndrome. 76
GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors 75
Chemotherapy alone for the treatment of early-stage Hodgkin's disease. 75
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia 75
BAVC regimen and autologous bone marrow transplantation for APL patients in second molecular remission: updated results. 74
Current trends in management of hepatitis B virus reactivation in the biologic therapy era 74
The role of restaging laparotomy in Hodgkin's disease. 74
Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming 73
A sustained CD16 aggregation induced by therapeutic antibody-opsonised targets impairs cytotoxic responses in human NK cells 72
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia 71
An acute promyelocytic leukaemia patient with a new atypical promyelocytic leukemia breakpoint 71
Role of NFIB in normal hematopoiesis and MyeloproliferativeNeoplasms 71
Umbilical cord blood transplant from unrelated HLA-mismatched donors in children with high risk leukemia 71
Elevated levels of miR-145 correlate with SMAD3 down-regulation in Cystic Fibrosis patients 71
Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy. 70
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 70
Analysis of the BCL-6 gene configuration in diffuse B-cell non-Hodgkin's lymphomas and Hodgkin's disease. 70
Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin's lymphoma 70
Solitary plasmacytoma of tibia: A possible correlation with younger age 70
CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients. 68
Comorbidities and FLT3-ITD Abnormalities as Independent Prognostic Indicators of Survival in Elderly Acute Myeloid Leukaemia Patients 68
Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene 68
A complete remission induced by valproic acid in a patient with essential thrombocytemia JAKV617F- positive 68
Late relapses in acute promyelocytic leukaemia 68
Thrombosis and survival in essential thrombocythemia: A regional study of 1,144 patients 67
ARTERIAL AND VENOUS THROMBOSIS IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: INCIDENCE AND RISK FACTORS IN A COHORT OF 1,491 PATIENTS 67
Acute leukaemia in patients treated for Hodgkin's disease 66
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatement in patients enrolled in the GIMEMA LAL 0496 protocol. 65
A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasms 65
Application of the International Prognostic Score of Thrombosis for Essential Thrombocytemia(ET) (IPSET-Thrombosis) in a Cohort of ET Patients: Experience from Gruppo Laziale for Myeloproliferative Ph Negative Neoplasms 65
A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: Clinical significance of treatment intensity and comprehensive geriatric assessment 65
High serum IL-2 levels are predictive of prolonged survival in multiple myeloma 64
Intracardiac thrombus in a patient with autoimmune hemolytic anemia leading to a diagnosis of antiphospholipid syndrome. 64
Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements. 64
Sequential Valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia. 64
MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. 64
Differential Toll like receptor expression in cystic fibrosis patients' airways during rhinovirus infection 64
Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin 64
Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid 64
Secondary acute non lymphoid leukemia in patients treated for non Hodgkin's lymphoma: No risk of therapy-related ANLL after PROVECIP schedule 63
Are ET and PV Patients Two Similar Populations As Concern Thrombotic Risk Factors? 63
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up. The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 62
Trisomy 13 in a patient with common acute lymphoblastic leukemia. Description of a case and review of the literature. 62
Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols 61
High serum interleukin-2 levels in acute myeloid leukaemia (AML) are associated with FAB M4 and M5 subtypes. 61
Prognostic Factors Associated With Progression of Smoldering Multiple Myeloma to Symptomatic Form 61
The t(4;11) chromosome translocation of human acute leukemias fuses the ALL1 gene, related to drosophila trithorax, to the AF4 gene 60
Negative impact of FLT3 abnormalities in elderly acute myeloid leukemia patients 60
Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia 60
A multiplex reverse transcription-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. 59
Survival after lung transplant for cystic fibrosis in italy. A single center experience with 20 years of follow-up 59
Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features 58
Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP) 58
THE (4 11)(Q21 Q23) CHROMOSOME TRANSLOCATIONS IN ACUTE LEUKEMIAS INVOLVE THE VDJ RECOMBINASE 58
Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum 57
A Genotypic-oriented View of CFTR Genetics Highlights Specific Mutational Patterns Underlying Clinical Macro-categories of Cystic Fibrosis. 57
FLT3 positive acute myeloid leukemia: A single center experience 57
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: An Italian Study Group report 57
Single daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignancies 57
A novel germline mutation in the 3'Untranslated region of Calreticulin gene induces JAK/STAT signaling activation and Erythrocytosis. 57
MOPP CHEMOTHERAPY VERSUS EXTENDED-FIELD RADIOTHERAPY IN THE MANAGEMENT OF PATHOLOGICAL STAGES I-IIA HODGKINS-DISEASE 56
Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leucemia. 56
Increased IL-8 production in human CFTR-deficient macrophages 56
A novel germline CALR mutation affecting an evolutionary conserved region of 3’UTR in JAK2-negative siblings with Polycythemia Vera 56
Risk Factors for Thrombosis Vary According to Age in Patients with Essential Thrombocythemia: a Retrospective Analysis of 1090 Patients from the "Gruppo Laziale SMPC Ph Negative 55
Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia 55
null 54
Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis. 54
Effects of hydration with salt repletion on renal toxicity of conventional amphotericin B empirical therapy: a prospective study in patients with hematological malignancies 54
Hodgkin lymphoma in pregnancy. Good news for clinicians and women 53
Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit 52
AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation. 52
Thrombosis History and Relationship with Low Thrombocytosis, Leukocytosis, and Jak2 V617F Mutation In A Cohort of 977 Patients with Essential Thrombocythemia (ET): Preliminary Report of the Registro Italiano Trombocitemia(RIT) 51
Second primary cancer following Hodgkin's disease: Updated results of an Italian multicentric study 51
IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP report 51
DHAP treatment: results of 18 patients with refractory or recurrent non Hodgkin's lymphoma. 51
null 50
Totale 6.916
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.600
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.324 0 0 0 0 0 0 301 286 257 244 152 84
2020/2021902 108 99 30 83 39 38 39 106 115 134 85 26
2021/20222.340 19 127 198 148 313 70 44 217 178 201 322 503
2022/20232.268 482 533 86 228 183 297 36 131 186 18 65 23
2023/2024962 76 148 35 63 92 112 36 48 9 127 95 121
2024/2025731 91 97 118 92 151 180 2 0 0 0 0 0
Totale 11.433